Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 23;25(5):2634.
doi: 10.3390/ijms25052634.

Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review

Affiliations
Review

Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review

Daniel Bastías et al. Int J Mol Sci. .

Abstract

Different efforts have been made to find better and less invasive methods for the diagnosis and prediction of oral cancer, such as the study of saliva as a source of biomarkers. The aim of this study was to perform a scoping review about salivary molecules that have been assessed as possible biomarkers for the diagnosis of oral squamous cell carcinoma (OSCC). A search was conducted using EBSCO, PubMed (MEDLINE), Scopus, and Web of Science. The research question was as follows: which molecules present in saliva have utility to be used as biomarkers for the early detection of oral cancer? Sixty-two studies were included. Over 100 molecules were assessed. Most of the markers were oriented towards the early diagnosis of OSCC and were classified based on their ability for detecting OSCC and oral potentially malignant disorders (OPMDs), OSCC outcome prediction, and the prediction of the malignant transformation of OPMDs. TNF-α, IL-1β, IL-6 IL-8, LDH, and MMP-9 were the most studied, with almost all studies reporting high sensitivity and specificity values. TNF-α, IL-1β, IL-6 IL-8, LDH, and MMP-9 are the most promising salivary biomarkers. However, more studies with larger cohorts are needed before translating the use of these biomarkers to clinical settings.

Keywords: biomarkers; mouth neoplasm; oral cancer; oral potentially malignant disorder; saliva.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow chart of selected studies.

Similar articles

Cited by

References

    1. Gualtero D.F., Suarez Castillo A. Acta Odontologica Scandinavica. Taylor and Francis Ltd.; Abingdon, UK: 2016. Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: A systematic review; pp. 170–177. - PubMed
    1. Warnakulasuriya S., Kujan O., Aguirre-Urizar J.M., Bagan J.V., González-Moles M., Kerr A.R., Lodi G., Mello F.W., Monteiro L., Ogden G.R., et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862–1880. doi: 10.1111/odi.13704. - DOI - PubMed
    1. Mello F.W., Miguel A.F.P., Dutra K.L., Porporatti A.L., Warnakulasuriya S., Guerra E.N.S., Rivero E.R.C. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J. Oral Pathol. Med. 2018;47:633–640. doi: 10.1111/jop.12726. - DOI - PubMed
    1. Iocca O., Sollecito T.P., Alawi F., Weinstein G.S., Newman J.G., De Virgilio A., Di Maio P., Spriano G., Pardiñas López S., Shanti R.M. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42:539–555. doi: 10.1002/hed.26006. - DOI - PubMed
    1. Al-Maweri S.A., Halboub E., Al-Qadhi G., Al-Wesabi M., Al-Sharani H.M., Parveen S., Alhashimi N., Almeslet A., Alhajj M.N. Efficacy of lycopene for management of oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2023;135:79–95. doi: 10.1016/j.oooo.2022.08.004. - DOI - PubMed